Clinical Trial Update: A Study of CTX-009 in Adult Patients With Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating CTX-009 in adults with metastatic colorectal cancer has completed, according to the trial record.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colon Cancer
• Colorectal Cancer
• Rectal Cancer

Drugs mentioned

• CTX-009 (CTX-009)

Snippet

Sponsor: Compass Therapeutics | Conditions: Metastatic Colorectal Cancer, Colon Cancer | Phase 2 | Status: COMPLETED